CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 230329-230535 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T22619","span":{"begin":0,"end":206},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In patients with a history of penicillin (PCN) allergy and negative PCN skin tests to major and minor determinants, 97-99% of patients will tolerate PCN administration without risk of an immediate reaction."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T389","span":{"begin":0,"end":206},"obj":"Sentence"}],"text":"In patients with a history of penicillin (PCN) allergy and negative PCN skin tests to major and minor determinants, 97-99% of patients will tolerate PCN administration without risk of an immediate reaction."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2107","span":{"begin":47,"end":54},"obj":"Disease"}],"attributes":[{"id":"A2107","pred":"mondo_id","subj":"T2107","obj":"http://purl.obolibrary.org/obo/MONDO_0005271"}],"text":"In patients with a history of penicillin (PCN) allergy and negative PCN skin tests to major and minor determinants, 97-99% of patients will tolerate PCN administration without risk of an immediate reaction."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T1042","span":{"begin":47,"end":54},"obj":"Phenotype"}],"attributes":[{"id":"A1042","pred":"hp_id","subj":"T1042","obj":"http://purl.obolibrary.org/obo/HP_0012393"}],"text":"In patients with a history of penicillin (PCN) allergy and negative PCN skin tests to major and minor determinants, 97-99% of patients will tolerate PCN administration without risk of an immediate reaction."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T464","span":{"begin":72,"end":76},"obj":"Body_part"}],"attributes":[{"id":"A464","pred":"uberon_id","subj":"T464","obj":"http://purl.obolibrary.org/obo/UBERON_0000014"}],"text":"In patients with a history of penicillin (PCN) allergy and negative PCN skin tests to major and minor determinants, 97-99% of patients will tolerate PCN administration without risk of an immediate reaction."}